Plus Therapeutics (PSTV) Misses Q2 EPS by 1c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.01). Revenue for the quarter came in at $1.39 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Paramount seeks $1.88B bond from state AGs to cover costs of WBD merger delay - CNBC